SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001126234-15-000163
Filing Date
2015-08-24
Accepted
2015-08-24 17:03:09
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A nlnk-20150331x10qa.htm 10-Q/A 34371
2 CEO CERTIFICATION nlnk-20150331xex311xa.htm EX-31.1 5019
3 CFO CERTIFICATION nlnk-20150331xex312xa.htm EX-31.2 5015
4 SECTION 1350 CERTIFICATION nlnk-20150331xex321xa.htm EX-32.1 8651
  Complete submission text file 0001126234-15-000163.txt   2290730

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nlnk-20150331.xml EX-101.INS 323516
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20150331.xsd EX-101.SCH 30090
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20150331_cal.xml EX-101.CAL 44825
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20150331_def.xml EX-101.DEF 141459
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20150331_lab.xml EX-101.LAB 416747
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20150331_pre.xml EX-101.PRE 213120
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35342 | Film No.: 151071547
SIC: 2834 Pharmaceutical Preparations